secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001606498-22-000077
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical reports Q3 2022 earnings; no specific data provided in filing excerpt
--------------------------------------------------------------------------------

- Quarter ended September 30, 2022 results disclosed on November 2, 2022.
- Key financial metrics (revenue, net income, EPS) not available from the supplied text.
- Investors should consult the full press release for complete details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649822000077/0001606498-22-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649822000077/avns-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001606498-22-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer